Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ12220,41
KB-1,06
PKN88,1488,171,39
Msft502,42502,51-0,16
Nokia4,274,2740,19
IBM282,66282,81-0,30
Mercedes-Benz Group AG51,9251,93-2,24
PFE25,4525,46-0,77
14.07.2025 16:55:05
Indexy online
AD Index online
select
AD Index online
 

  • 14.07.2025 16:46:28
GFT Technologies (GFTG.DE, Xetra)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
22,70 -2,78 -0,65 707 018
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.07.2025
Popis společnosti

Business Summary: GFT Technologies SE (GFT SE) is a Germany-based parent company of the GFT Group, an international supplier of information technology (IT) solutions. The Company divides its activities into two divisions: GFT (formerly GFT Solutions) and Emagine. The Company specializes in designing and implementing IT solutions for the financial services industry. It is engaged in the design, delivery and maintenance of customized Information Technology solutions. The Company also designs business models to optimize and mobilize banking processes for the financial sector. In addition, it is engaged in the provision of sourcing IT specialists and consultancy services for companies in various sectors. In addition, the Company manages external Information Technology service providers for its clients. The Company's subsidiaries are present in Brazil, Germany, France, Italy, the United Kingdom, Spain, Switzerland and the United States.
Financial Summary: BRIEF: For the three months ended 31 March 2025, GFT Technologies SE revenues increased 4% to EUR221.9M. Net income decreased 33% to EUR7.1M. Revenues reflect Americas & UK APAC segment increase of 10% to EUR129.6M. Net income was offset by Personnel expenses increase of 9% to EUR164.2M (expense), Other operating expenses increase of 3% to EUR16.3M (expense).



  • Poslední aktualizace: 14.07.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Executive Chairman of the BoardSaid Darwazah6601.09.202301.07.2007
Chief Executive Officer, Executive DirectorRiad Mishlawi-01.09.202301.01.2011
Executive Vice Chairman of the Board, President of MENAMazen Darwazah-08.09.2005
Chief Financial OfficerKhalid Nabilsi-01.01.2008
President - GenericsHafrun Fridriksdottir-15.04.202415.04.2024
President - InjectablesBill Larkins-01.09.202301.09.2023
Chief People OfficerHussein Arkhagha-01.01.2013
Executive Vice President - Strategic Planning and Global AffairsSusan Ringdal-
Executive Vice President - Corporate Development and M and ABassam Wael Roshdi Kanaan59
Senior Vice President - Corporate Quality Compliance and Health and SafetyJulie Hill-